B6.Cg-Tg(TG-cre/ERT2)248Ubc/Kctt
| Status | Available to order |
| EMMA ID | EM:04909 |
| Citation information | RRID:IMSR_EM:04909 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | B6.Cg-Tg(TG-cre/ERT2)248Ubc/Kctt |
| Alternative name | TG-Cre-ERT2 #248 |
| Strain type | Transgenic Strains |
| Allele/Transgene symbol | Tg(TG-cre/ERT2)248Ubc |
| Gene/Transgene symbol | Tg(TG-cre/ERT2)248Ubc |
Information from provider
| Provider | Nils-Erik Heldin |
| Provider affiliation | Dept of Genetics and Pathology, Uppsala University |
| Genetic information | A transgenic mouse (called TG-Cre-ERT2) with thyroid-specific tamoxifen-inducible expression of the cre recombinase gene. The expression of the CRE-ERT2 gene is under control of a 2 kb thyroglobulin (TG) promoter. |
| Phenotypic information | No phenotype. |
| Breeding history | Backcrossed 10 times to C57BL/6. |
| References | None available |
| Homozygous fertile | yes |
| Homozygous viable | yes |
| Homozygous matings required | no |
| Immunocompromised | no |
Information from EMMA
| Archiving centre | Karolinska Institutet, Stockholm, Sweden |